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Highlights  
 There is no standard tool for measuring the symptoms of the bipolar prodrome, which has limited 
progress toward early identification 
 The clinician-administered Bipolar Prodrome Symptom Interview and Scale–Full Prospective 
(BPSS-FP) is a valid way to assess for symptoms of the prodrome to bipolar disorder, but takes 
time and clinical expertise to administer 
 The Bipolar Prodrome Symptom Scale-Abbreviated Screen for Patients (BPSS-AS-P) is a 
screening tool to identify people who would benefit from further evaluation with the BPSS-FP 
interview 
 This study is an important step in the development and validation of a screening tool that could be 
an efficient way to identify individuals at risk for bipolar disorder 
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Abstract 
Objective 
There is no standard method for assessing symptoms of the prodrome to bipolar disorder (BD), which has 
limited progress toward early identification and intervention. We aimed to validate the Bipolar Prodrome 
Symptom Scale–Abbreviated Screen for Patients (BPSS-AS-P), a brief self-report derived from the 
validated, clinician-rated Bipolar Prodrome Symptom Interview and Scale–Full Prospective (BPSS-FP), 
as a means to screen and identify people for whom further evaluation is indicated.  
 
Method 
Altogether, 134 participants (aged 12-18 years) were drawn from a study of the pre-syndromal stage of 
mood and psychotic disorders. All participants had chart diagnoses of a mood- or psychosis-spectrum 
disorder. Participants were interviewed with the BPSS-FP and completed measures of mania and non-
mood psychopathology. Prior to being interviewed, patients completed the BPSS-AS-P. Scores on the 
BPSS-AS-P were determined by summing the severity and frequency ratings for each item.  
 
Results 
BPSS-AS-P scores were highly reliable (Cronbach’s alpha=0.94) and correlated with the interview-based 
BPSS-FP Mania Symptom Index (r=0.55, p<.0001). BPSS-AS-P scores had good convergent validity, 
correlating with the General Behavior Inventory-10M (r=.65, p<.0001) and Young Mania Rating Scale; 
r=.48, p<.0001). The BPSS-AS-P had good discriminant validity, not being correlated with scales 
measuring positive and negative symptoms of psychotic disorders (p-values=0.072-0.667). 
 
Limitations 
Findings are limited by the cross-sectional nature of the study by the fact that the participants were all 
treatment-seeking. Future studies need to evaluate the predictive validity of the BPSS-AS-P for 
identifying those who develop BD in a community sample. 
 
Conclusion 
BPSS-AS-P has promise as a screening tool for people at risk for BD. Adopting the BPSS-AS-P would 
support the goal of characterizing the prodrome systematically in order to facilitate research and clinical 
care.  
 
Key words: prodrome, assessment, bipolar disorder, validation 
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Substantial evidence from retrospective studies suggests that the majority of people with bipolar 
disorder (BD) experience symptoms prior to the point at which they meet full diagnostic criteria (Correll 
et al., 2014a; Howes et al., 2010; Martin, 2013; Skjelstad, Malt, & Holte, 2010). Related, following 
diagnosis, many people report that they are able to recognize when a new episode is impending based on 
changes in their energy, sleep, or mood, among others (Jackson, Cavanagh, & Scott, 2003; Lam, Wong, 
& Sham, 2001; Molnar, Feeney, & Fava, 1988). Being able to predict the onset of a new episode is 
advantageous; people with BD or their families can seek and obtain clinical intervention, which may 
reduce the severity of the new mood episode and/or the consequences associated with it (Lam & Wong, 
1997, 2005; Perry, Tarrier, Morriss, McCarthy, & Limb, 1999). In some instances, it may even be 
possible to prevent the BD onset (Colom et al., 2009; Lam, Watkins, Hayward, & et al., 2003).  
 Although monitoring symptoms is recommended for people with BD in order to detect clinical 
changes and intervene accordingly (Miller, Johnson, & Eisner, 2009; Schwartz, Schultz, Reider, & 
Saunders, 2016), this approach has not been applied to individuals who are considered at-risk for BD. A 
meta-analysis found that there are clear mood symptoms prior to both initial and recurrent bipolar mood 
episodes, and that the duration of the prodrome to the onset of the first mood episode (107.9 ± 91.5 
months) is longer than that of the recurrent prodrome (1.1 ± 1.0 months; Van Meter, Burke, Youngstrom, 
Faedda, & Correll, 2016). This finding suggests that there is an opportunity for preventive intervention, 
but no unified or generally accepted approach to evaluating and treating the BD prodrome exists. In 
contrast, the prodrome of schizophrenia has been studied extensively, yielding standardized interviews 
and self-rating scales that facilitate placement into specialized treatment programs for young people 
experiencing early symptoms of psychosis (Correll, Hauser, Auther, & Cornblatt, 2010; Davies, 2018; 
Fusar-Poli et al., 2012; Fusar-Poli, Cappucciati, Borgwardt, & et al., 2016; Fusar-Poli et al., 2015; Kline 
et al., 2015; Loewy, Pearson, Vinogradov, Bearden, & Cannon, 2011; Marshall & Rathbone, 2011; Savill, 
D'ambrosio, Cannon, & Loewy, 2018).  
 One of the reasons that the process of defining and treating the BD prodrome lags behind that of 
the schizophrenia prodrome is that many symptoms associated with the BD prodrome are nonspecific 
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(e.g., sleep disturbances, diminished ability to think, irritability; Van Meter et al., 2016), making them 
difficult, in some cases, to distinguish clinically from other disorders, such as depression, ADHD, or 
oppositional defiant disorder. This is understandable, as the threshold for mania has not yet been met, but 
it is detrimental for treatment, as inaccurate diagnoses (and the wrong intervention) can persist even as 
symptoms escalate.  
 A related factor is that clinical decision-making is imperfect (Lilienfeld & Lynn, 2014; 
Youngstrom, Choukas-Bradley, Calhoun, & Jensen-Doss, 2014), and clinicians often make invalid 
diagnostic decisions even for diagnoses with well-defined criteria. Because the symptoms that constitute 
the prodrome to BD have not yet been well-characterized, the likelihood of it being recognized is very 
low. Tools that help to focus the clinical decision-making process have demonstrated success at 
improving the accuracy and efficiency of diagnosing BD when incorporated into the assessment process 
(Youngstrom et al., 2018; Youngstrom, Genzlinger, Egerton, & Van Meter, 2015; Youngstrom et al., 
2017). If a screening tool for the prodrome existed, it could aid in the identification of at-risk cases. 
 A structured interview, the Bipolar Prodrome Symptom Interview and Scale – Full Prospective 
(BPSS-FP; Correll et al., 2014b), was developed to facilitate recognition of the prodrome to BD. It has 
strong reliability and validity to identify people at elevated risk for the onset of a bipolar mood episode. 
However, the interview requires time and clinical judgment, which makes it impractical to administer to 
all patients with subthreshold mood symptoms. Consequently, we developed a brief self-report, the 11-
item BPSS-Abbreviated Screen for Patients (BPSS-AS-P), based on the BPSS-FP to screen people who 
may be experiencing prodromal symptoms, in order to identify those who could benefit from further, 
more detailed, clinician-based assessment. Individuals at the age of highest risk for the onset of BD are 
among those least likely to engage with mental health services (Heflinger & Hinshaw, 2010; Husky et al., 
2012; McGorry, Bates, & Birchwood, 2013); this fact may contribute to the long delays (on average more 
than ten years; Lish, Dime-Meenan, Whybrow, Price, & Hirschfeld, 1994; Perlis et al., 2004) that are 
common before people with BD get an accurate diagnosis. This issue highlights the importance of a brief 
screening tool; if successful at identifying elevated risk for BD, the BPSS-AS-P could be used to screen 
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for the BD prodrome broadly – in schools or through pediatricians – which would facilitate early 
identification independent of treatment seeking behavior. 
 The goal of the present study was to examine the psychometric properties of the BPSS-AS-P in a 
sample of treatment-seeking young people with symptoms of mood- or psychosis-spectrum disorders. 
Adolescence is the period during which most people experience the onset of BD (Baldessarini et al., 
2012; Bellivier et al., 2014), making this the age range especially relevant for an examination of a tool to 
identify people at risk. We evaluated the correlation between the short screening tool and the full-length 
interview. Additionally, we tested the convergent and discriminant validity of the short screening tool. 
Methods 
Participants 
Participants were drawn from the ongoing Adolescent Mood Disorder and Psychosis Study 
(AMDS) study (clinicaltrials.gov: NCT01383915). AMDS is an ongoing longitudinal study that aims to 
characterize the pre-syndromal stage of mood and psychotic disorders. Participants undergo 
comprehensive, non-invasive interview/survey assessments every 12 months for up to five years. All 
participants were recruited from inpatient and outpatient facilities at a single, semi-urban, psychiatric 
hospital with a catchment population of over three million people, covering Queens, Brooklyn, and 
counties on Long Island, New York. The present study focuses on the baseline data only. At enrollment, 
participants were between the ages of 12 and 18 years old. All had chart diagnoses of a mood- or 
psychosis-spectrum disorder (including DSM-IV diagnoses of Bipolar Disorder I (BD I), Bipolar 
Disorder II (BD II) BD-Not Otherwise Specified (BP-NOS), mood disorder NOS, Major Depressive 
Disorder (MDD), depressive disorder NOS, dysthymia, or schizophrenia, schizoaffective disorder, 
schizophreniform disorder, acute psychotic disorder, or psychotic disorder NOS). The study focused on 
these diagnoses because young people with mood symptoms (i.e., hypomania, depression, subthreshold 
manic symptoms) are at high risk for the onset of a manic episode, increasing the likelihood that some 
participants would experience a manic episode during the study period and enabling us to evaluate the 
predictive abilities of the BPSS-AS-P. Although this feature limits the generalizability of our results to 
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other settings (e.g., community mental health, pediatrician offices), given the low rate of mania, even 
among high-risk samples, we felt that it was important to maximize the number of mania cases at this 
stage of the BPSS-AS-P development. Additionally, participants with psychotic disorder diagnoses were 
of interest because they are likely to have a similar level of symptomatology as people with bipolar 
disorder, but are not at risk for mania, making them a clinically relevant comparison group. Exclusion 
criteria were minimal; potential participants were not enrolled if they could not speak and read English, if 
they had an estimated IQ < 70 or a developmental disorder, if they had a current substance use disorder, 
or if they had a known organic brain condition. This study was approved by the Institutional Review 
Board at the large academic medical center where it took place; all participants and caregivers provided 
written informed assent or consent. 
Procedure 
The participant and a caregiver were each interviewed separately by a trained medical doctor or 
psychologist in one session (unless the patient was too ill to complete the interviews in one session, in 
which case the patient interview was completed within the next one-to-three days). The baseline session 
lasted several hours and included the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID; 
First, Spitzer, Gibbon, & Williams, 1995), on which DSM diagnoses were based, the clinician-rated 
Bipolar Prodrome Symptom Scale–Full Prospective (BPSS-FP; Correll et al., 2014b), and the clinician-
rated Brief Psychiatric Rating Scale-anchored version (BPRS; Woerner, Mannuzza, & Kane, 1988). The 
SCID was supplemented with modules from the Schedule for Affective Disorders and Schizophrenia for 
School-Age Children-Present and Lifetime Version (Kaufman et al., 1997) for disorders of childhood that 
are not covered in the SCID (e.g., oppositional defiant disorder). Each participant was assigned a research 
diagnosis following a consensus meeting led by the study principle investigator and last author of this 
report, a board-certified child and adolescent psychiatrist, at which all sources of information were 
discussed and integrated. The BPSS-FP assesses putative symptoms and signs of the prodrome to BD and 
is split into three sections – the Mania Symptom Index, Depression Symptom Index, and General 
Symptom Index. Each symptom is rated on a six-point scale according to its severity. In a validation 
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study of the BPSS-FP (Correll et al., 2014b), internal consistency was good to very good for the Mania 
(Cronbach's α = 0.87), Depression (Cronbach's α = 0.89), and General Symptom indices (Cronbach's α = 
0.74). Inter-rater reliability was high for the total score (ICC = 0.939), as well as for the Mania (ICC = 
0.934), Depression (ICC = 0.985), and General (ICC = 0.981) indices. Correlations were large (ρ ≥ 0.50) 
between the Mania Index and other measures of manic symptoms. Related, correlations were small (ρ = 
0.10 to < 0.30) between the Mania Index and measures of depressive symptoms. Furthermore, the 
discriminant validity of the BPSS-FP and its subscales was high. The BPRS, a clinician-rated measure of 
current psychotic symptoms, consists of 18 items, rated 1-7, that form five factor scales – Withdrawal-
Retardation, Thinking Disturbance, Anxious-Depression, Hostile-Suspiciousness, and Activation. 
Reliability for participant BPRS factor scores was high (Cronbach’s αs=0.91-0.97). Caregivers were 
interviewed about the participant’s family history of mental health disorders using the Family Interview 
for Genetic Studies (FIGS; Maxwell, 1992). 
Additionally, before the clinician administered BPSS-FP, we administered the Bipolar Prodrome 
Symptom Scale – Abbreviated Screen for patients (BPSS-AS-P) to screen for the presence of attenuated 
and/or subsyndromal mania symptoms. The BPSS-AS-P (see appendix) was developed as a self-rated 
companion scale of the clinician-administered BPSS-FP. BPSS-FP (Correll et al. 2014b) is a semi-structured 
interview that was developed based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) criteria for BD and MDD, as well as established rating scales for mania, depression, and other 
psychopathology. In addition, the BPSS-FP development was based on the BPSS-Retrospective (Correll et al. 
2014a), which was informed by a review of existing literature regarding risk factors and early symptoms of BD, 
published scales and interviews for the assessment of the psychotic prodrome and character traits, input from experts 
in the areas of the schizophrenia prodrome and BD, and open questioning of youth with BD and their caregivers 
regarding emerging subthreshold symptoms prior to the onset of a first syndromal bipolar manic, mixed, and major 
depressive episode. The BPSS-AS-P contains 10 BPSS-FP mania index items that directly map on the 
DSM-IV and DSM-5 mania criteria and that were rephrased from interviewer-based language to allow 
patient-reported self-rating. The General index item ―mood lability‖ was added, as mood lability is a 
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common symptom during the bipolar prodrome (Van Meter et al. 2016; Hafeman et al. 2016). The BPSS-
AS-P originally had 14 items, but we only analyzed the 11 items that match the 10-item the Mania 
Symptom Index from the BPSS-FP plus the General Symptom Index item ―mood lability.‖ We excluded 
the items targeting ―being more social and outgoing or flirtatious,‖ ―being dressed more colorfully or 
unusually, or putting on more make-up,‖ and ―being more creative than usual,‖ which had been added as 
exploratory items based on another utilized bipolar high-risk assessment schedule (Leopold et al, 2012), 
as these items are not contained in the BPSS-FP. 
Participants also completed questionnaires to assess their personal history, functioning, and 
symptoms of psychopathology. The 10-item mania checklist from the General Behavior Inventory (GBI-
10M; Youngstrom, Van Meter, Frazier, Youngstrom, & Findling, in press; Youngstrom, 2008) is a 
screening tool for the diagnosis of bipolar disorder; in multiple studies, it has demonstrated excellent 
sensitivity to differences in manic symptoms (Findling et al., 2009; Youngstrom et al., 2013). It was also 
used as the basis of inclusion for the Longitudinal Assessment of Manic Symptoms study (LAMS; 
Horwitz et al., 2010). The GBI-10M was completed about the past month by the participant; reliability for 
the self-report was excellent (Cronbach’s α=0.92). The other measure of mania was the Young Mania 
Rating Scale (YMRS; Young, Biggs, Ziegler, & Meyer, 1978). The YMRS includes ten items that are 
rated by the interviewer about the past month, based on his/her impressions of the participant. In our 
sample, the YMRS had adequate reliability, Cronbach’s α=0.80.  
Data analytic plan 
The goal of this study was to validate the patient self-report BPSS-AS-P, and to determine 
whether it has utility as a screening tool to identify individuals who might be at risk for developing 
bipolar disorder, who could then be further evaluated with an interview like the BPSS-FP. Although the 
BPSS-FP evaluates symptoms across multiple domains (mania, depression, general symptoms), the 
BPSS-AS-P focuses on ten items assessing mania-related symptoms and one question on mood lability, 
which is part of the general symptom index of the BPSS-FP (Correll et al., 2014b). Consequently, we 
focused on mania-related measures and on the Mania Symptom Index of the BPSS-FP to validate the 
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BPSS-AS-P. We also performed an exploratory factor analysis of the BPSS-AS-P severity items. IRT 
analyses used a rating scale model to estimate item characteristics and reliability across levels of the 
mania trait. 
We evaluated different score thresholds of the BPSS-AS-P in order to determine which best 
mapped onto the mania score from the BPSS-FP. The BPSS-AS-P consists of 11 items, each of which is 
rated on its severity (0=no impact, 5=severe impact) and its frequency (0=not at all, 5=almost all the 
time). First, we created a raw score, summing both the severity and frequency ratings across items; this is 
the raw summed total score. Next, we looked at the summed severity ratings (raw severity score) and 
summed frequency ratings (raw frequency score) separately. We then created a priori, based on clinical 
considerations of progressively severe and frequent, and, possibly, more specific states, four threshold 
scores; threshold one (mild severity-mild frequency) is a count of the items that were rated at least a 3 on 
severity (some impact) and at least a 2 on frequency (once a month). Threshold two (mild severity-
moderate frequency) is a count of the items that were rated at least a 3 on severity (some impact) and at 
least a 3 on frequency (once a week). Threshold three (moderate severity-mild frequency) is a count of 
the items that were rated at least a 4 on severity (a lot of impact) and at least a 2 on frequency (once a 
month). Threshold four (moderate severity-moderate frequency) is a count of the items that were rated at 
least a 4 on severity (a lot of impact) and at least a 3 on frequency (once a week).  
Given that our sample included both prepubertal youth and adolescents, who – based on age – are 
at different levels of risk for the onset of BD and may have different clinical presentations (Birmaher et 
al., 2009; Goldstein et al., 2017), and because there is some limited evidence of sex differences in 
symptom presentation (Duax, Youngstrom, Calabrese, & Findling, 2007; Sibisi, 1990; Wozniak et al., 
2013), we evaluated whether any of the scores produced by the methods described above were influenced 
by age or sex, in order to determine whether it was necessary to control for these variables in subsequent 
analyses.  
Next, each method of scoring was compared with the Mania Symptom Index severity score from 
the participant’s BPSS-FP interview using Pearson’s correlation. Additionally, although the purpose of 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
BPSS-AS-P VALIDATION 11 
 
the BPSS-AS-P is not diagnosis, as it is intended to identify those at risk for BD, we expected it to 
distinguish those with BD from patients with other diagnoses. In order to test this hypothesis, we 
performed receiver operating characteristic (ROC) analyses using each of the BPSS-AS-P scoring 
methods and compared these to the performance of the interview score using Venkatraman’s permutation 
test (Venkatraman, 2000; Venkatraman & Begg, 1996), which evaluates equality of two ROC curves by 
examining the absolute difference between the two at each point along the curves (Venkatraman & Begg, 
1996). Following these analyses (correlations and ROC), if one scoring method emerged as the most 
effective and efficient, we planned to focus on that one for the remaining analyses for simplicity and 
clarity.  
Cronbach’s alpha was calculated to determine the internal reliability of the BPSS-AS-P. Because 
individuals experiencing symptoms of mania may have limited insight, we also examined the association 
between self-reported BPSS-AS-P and the parent interview BPSS-FP; a strong association between the 
self-report and parent interview would support the utility of the BPSS-AS-P. Next, we tested the 
convergent and divergent validity of the BPSS-AS-P by comparing scores to other common screening or 
rating tools for BD (GBI-10M, YMRS) and to another measure of non-bipolar psychopathology (BPRS 
total score and subscales).  
Results 
Demographic and descriptive variables 
The sample included 134 people who completed the BPSS-AS-P at baseline. The average age at 
baseline was 15.6 (1.4), 73% were female, 60% were White, 17% were Black, 10% were Asian, and 13% 
identified as Other. The majority of the participants were diagnosed with depressive disorders (60%), 
24% had a bipolar disorder diagnosis, 16% had other, non-mood disorder diagnoses (see Table 1). There 
were no statistically-significant differences in demographic or clinical characteristics between the groups. 
Evaluation of thresholds for “caseness” 
Each item on the BPSS-AS-P is rated on both severity (how pronounced the symptoms are and 
and/or much functioning is impacted) and frequency (how often the symptom occurs). See Table 2 for 
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average scores on the BPSS-AS-P, as well as the other clinical scales. We evaluated how well the self-
report correlated with the BPSS-FP Mania Symptom Index at different thresholds, as described in the 
Analytic Plan. Correlations ranged from 0.45 (for the moderate thresholds of both the severity and 
frequency ratings) to 0.53 (for the raw summed frequency and combined severity and frequency ratings), 
all p-values were <0.0001 (Table 3). 
We also evaluated the diagnostic efficiency of each threshold using receiver operating 
characteristic analysis; AUCs ranged from 0.64 (for the moderate severity-moderate frequency threshold) 
to 0.73 for the raw summed total score. The AUC for the BPSS-FP Mania Symptom Index severity score 
was 0.82; Venkatraman’s test indicated this was significantly better than the AUCs for thresholds three 
and four (p-values<0.05). Similarly, the AUC for the raw summed BPSS-AS-P severity and frequency 
ratings was significantly better than the AUCs for thresholds three and four (p-values<0.05).  
Given that summing the severity and frequency ratings to create a single score is among the 
simplest approaches to scoring, and because this approach performed as well as or better than the other 
evaluated scoring methods, there did not seem to be any benefit to using a more complicated scoring 
algorithm. Subsequent analyses focused on this raw summed total score. 
Neither age nor sex were related to any of the scores produced for the BPSS-AS-P (as described 
above), consequently, we did not control for demographic factors in subsequent analyses. 
Factor and item response theory analyses 
The factor structure of the BPSS-AS-P was evaluated using exploratory factor analysis with 
principal axis factoring and promax rotation. The Kaiser-Meyer-Olkin measure of indicated ―meritorious‖ 
sampling adequacy (KMO=0.89; Kaiser, 1974) and Bartlett’s test of sphericity was significant 
(X
2
(55)=508.48, p<0.0001; Snedecor & Cochran, 1989). Both the scree plot and eigenvalues suggested a 
two-factor solution, which explained 57% of the variance. One factor was indicated by five items (#1, 3, 
4, 5, 8) related to positive aspects of mania (e.g., elated mood, increased energy); it explained 46% of the 
variance. The other factor was indicated by six items (#2, 6, 7, 9, 10, 11) related to the negative aspects of 
mania (e.g., irritability, risky behavior); it explained 11% of the variance. 
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The IRT model was also estimated using the rating scale model; the BPSS-AS-P severity items 
fulfilled the Rasch model for unidimensionality (X
2
(14)=22.92, p=.062), and the model fit the data well 
(RMSEA =.03). Additionally, items were invariant across those with a diagnosis of BD and those 
without; X
2
(14)=19.08, p=.162. Person separation reliability was good, 0.88. 
 
Reliability  
Calculating Cronbach’s alpha for the summed severity and frequency items, the reliability was 
excellent (α=0.94). 
Convergent and discriminant validity 
In addition to comparing the BPSS-AS-P to the clinician-rated BPSS-FP Mania Symptom Index, 
we also examined how well it correlated with the parent BPSS-FP Mania Symptom Index; the scales were 
moderately correlated (r=0.44, p<0.0001). We also examined correlations between the BPSS-AS-P and 
other commonly used screening tools for mania. The summed score of the BPSS-AS-P was highly 
correlated with the self-report GBI-10M (r=0.65, p<0.0001) and moderately correlated with the clinician-
rated YMRS (r=0.48, p<0.0001).  
We also evaluated the discriminant validity of the BPSS-AS-P by comparing the raw summed 
total score to the five symptom scales of the BPRS. None of the correlations between the BPSS-AS-P and 
the BPRS total score or subscales were statistically significant (rs=-0.09-0.18; ps=.072-.667), indicating 
that the content of the BPSS-AS-P does not overlap with scales measuring the positive and negative 
symptoms associated with psychotic disorders. 
Discussion 
Bipolar disorder is challenging to diagnose (Berk, Berk, Moss, Dodd, & Malhi, 2006; 
Bruchmüller & Meyer, 2009; Youngstrom, Birmaher, & Findling, 2008); consequently, many individuals 
experience long delays before appropriate treatment is administered (Berk et al., 2006; Berk et al., 2010; 
Drancourt et al., 2013; Elanjithara, Frangou, & McGuire, 2011; Lish, Dime-Meenan, Whybrow, Price, & 
Hirschfeld, 1994; Perlis et al., 2004). Improving methods for early identification and intervention are 
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important goals, but have been stymied by lack of consistency in the measurement and description of the 
prodrome and by the reliance on retrospective reports of prodromal symptoms (Faedda et al., 2014; Van 
Meter et al., 2016). The BPSS-FP was developed to address these challenges and has demonstrated strong 
psychometric properties for the identification of the prodrome to bipolar disorder. However, this 
interview-based tool requires significant time and clinical skill to administer. In contrast, the BPSS-AS-P 
is brief and can be administered broadly to in order to identify individuals who might be at-risk and 
would benefit from further evaluation with the interview. 
The goal of the present study was to validate the BPSS-AS-P as tool to screen for degrees of 
symptoms of mania in a clinical sample. We found that the BPSS-AS-P parallels scores from lengthy and 
time consuming, clinician-based interview of patients using the full-length interview version of the BPSS, 
and that it correlates well with other measures of manic symptoms, as completed by the patient, his/her 
caregiver, and a clinician.  
The 11 items of the BPSS-AS-P focus on manic symptoms and mood lability. Although previous 
work suggests that not all symptoms common during the prodrome are specific to mania (Van Meter et 
al., 2016), non-manic symptoms are likely to overlap with other disorders, making them less helpful in 
identifying those at risk for a manic episode. The specificity of the 11 items is indicated by the high 
correlations we found with other manic symptom scales. Additionally, because we compared scores on 
the BPSS-AS-P with the YMRS, a clinician-rated measure, we see that the BPSS-AS-P – a self-report – 
captures symptoms in a way that corresponds well with clinical impressions. This feature is important; the 
prodrome is most likely to occur during adolescence or early adulthood, and broad screening will be more 
feasible if there is a brief, self-report tool that eliminates the need to interview each youth directly.  
Our results also indicate that the BPSS-AS-P has good discriminative validity – scores were not 
correlated with the BPRS scales measuring the positive and negative symptoms of psychotic disorders. 
This is a key finding; many have speculated that, at the prodromal stage, it is difficult or impossible to 
distinguish those likely to develop mania from those likely to develop schizophrenia or another non-mood 
psychotic disorder, but in our study, the BPSS-AS-P appears to be specific to mania. Additionally, the 
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results of the IRT and factor analyses are consistent with a unidimensional trait; although a two-factor 
structure fit best, the second factor explained a minimal amount of variance. Interestingly, these results 
are consistent with other work that has identified different components of mania (Topor et al., 2013; 
Benazzi & Akiskal, 2003), and with patients’ experiences, which can vary from ―irritable‖ to ―elated‖ 
presentations. 
 Being able to rely on self-report could also facilitate the adoption of the BPSS-AS-P by other 
research groups. As noted above, the use of many different tools to measure the prodrome to BD has 
limited our understanding of this critical phase of illness development (Van Meter et al., 2016). Related, 
the referral source is likely to influence patient characteristics in important ways; for example, 
participants with a family history of illness may be likely to experience symptoms earlier than their peers 
(Johnson, Andersson-Lundman, Åberg-Wistedt, & Mathé, 2000; Post et al., 2017; Post et al., 2014). In 
order to improve the characterization of the prodrome to BD, including its key symptom profiles and 
duration, it is necessary to collect data in a systematic way from diverse populations. The BPSS-AS-P 
offers a simple and fast way by which to identify those who would benefit from further evaluation and 
whose data will be instrumental to informing future efforts to identify the prodrome, in order to intervene 
before an individual experiences the full consequences of BD. 
Limitations. Predicting who is likely to develop mania is an ambitious goal; an important next 
step in this pursuit is the longitudinal follow-up of individuals who have completed the BPSS-AS-P. 
Although our results suggest strong associations between the BPSS-AS-P, the BPSS-FP, and other 
measures of mania, the data are still cross-sectional, so we do not yet know how well the BPSS-AS-P 
predicts who will go on to have a manic or hypomanic episode. In addition to the lack of longitudinal 
data, our findings are limited by the fact that our data were from individuals already experiencing 
significant symptoms and seeking treatment. The sample in which a screening tool is validated influences 
its performance (Youngstrom et al., 2018; Youngstrom et al., 2015), and it is important to evaluate the 
psychometric properties of the BPSS-AS-P in people who are not yet in clinical care before undertaking 
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broad screening efforts. Moreover, due to the lengthy baseline assessments, we did not ask patients and 
families to return for test-retest reliability testing of the BPSS-AS-P.  
Conclusion  
In spite of clear evidence that early intervention is associated with better outcomes for individuals 
with bipolar disorder (Berk et al., 2007; Elanjithara et al., 2011), progress has been slow to characterize 
the prodrome to BD in a way that facilitates identification and intervention. The BPSS-FP was developed 
to identify people at risk for BD, but it requires significant time and clinical resources. The BPSS-AS-P 
offers a valid way to screen people for bipolar risk and to identify those who would benefit from further 
evaluation. In this initial validation study, the BPSS-AS-P showed strong convergent and divergent 
validity. Using this tool across populations to identify those who may be at risk for mania, especially 
longitudinally, is the necessary next step in the goal of reducing the long delay most patients experience 
before getting the treatment they need to achieve the quality of life they deserve.  
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Table 1. 
 
Clinical characteristics across diagnostic groups* 
 
  Full sample Bipolar 
spectrum 
disorder 
Depressive 
disorder 
No mood 
disorder 
n 134 32 81 21 
 Mean (SD) 
Age  15.63(1.4) 15.84(1.3) 15.60(1.4) 15.39(1.6) 
 N (%) 
Female
1
 95 (70.9) 25 (78.1) 59 (73.8) 11 (61.1) 
White
2
 71 (59.7) 17 (58.6) 45 (61.6) 9 (52.9) 
Black
2
 20 (16.8) 5 (17.2) 11 (15.1) 4 (23.5) 
Hispanic
3
 24 (32.4) 8 (42.1) 15 (33.3) 1 (10.0) 
Asian
2
 12 (10.0) 1 (3.4) 8 (10.9) 3 (17.6) 
Family history of bipolar disorder 13 (9.7) 5 (15.6) 5 (6.1) 3 (14.2) 
Bipolar I 7 (5.2) 7 (21.8) 0 (0.0) 0 (0.0) 
Bipolar II 6 (4.4) 6 (18.7) 0 (0.0) 0 (0.0) 
Bipolar NOS 19 (14.1) 19 (59.3) 0 (0.0) 0 (0.0) 
Major depressive disorder 64 (47.7) 0 (0.0) 64 (79.0) 0 (0.0) 
Other depressive disorder 17 (12.6) 0 (0.0) 17 (20.9) 0 (0.0) 
Attention deficit/hyperactivity disorder 12 (8.9) 10 (31.2) 0 (0.0) 2 (9.5) 
Anxiety disorder or OCD 10 (7.4) 3 (9.3) 3 (3.7) 4 (19.0) 
Disruptive behavior disorder 17 (12.6) 5 (15.6) 11 (13.5) 1 (4.7) 
Eating disorder 2 (1.4) 0 (0.0) 2 (2.4) 0 (0.0) 
1
 – data missing for four people 
2 
– data missing for 15 people 
3 
– data missing for 60 people 
* there were no statistically-significant differences between any of the groups on these characteristics 
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Table 2.  
 
Rating scale scores across diagnostic groups 
 
 Bipolar spectrum disorder Depressive 
disorder 
No mood 
disorder 
   
n 32 81 21    
 Mean (SD) Cohen’s d Cohen’s d Cohen’s d 
BD vs DD BD vs NMD DD vs NMD 
Age  15.84(1.3) 15.60(1.4) 15.39(1.6) 0.17, p=.712 0.31, p=.541 0.14, p=.838 
Patient-Rated Instruments  Mean (SD)       
BPSS-AS-P severity 30.87(12.8) 17.26(10.7) 20.00(12.8) 1.16,p<.0001 0.85,p=.003 -0.23,p=.604 
BPSS-AS-P frequency 30.00(11.6) 18.19(10.8) 21.23(10.5) 1.05,p<.0001 0.79,p=.014 -0.29,p=.492 
BPSS-AS-P total 59.91(24.0) 34.38(20.5) 41.24(22.3) 1.15,p<.0001 0.81,p=.007 -0.32,p=401 
GBI-10M 25.48(7.8) 17.26(7.1) 18.77(8.2) 1.10,p=.021 0.84,p<.0001 0.20,p=.779 
Parent-rated Instruments Mean (SD)  
Patient BPSS-FP Mania 
Index severity 
24.23(14.4) 9.44(7.3) 16.38(11.7) 
1.37,p<.0001 0.60,p=.132 -0.73, p=.160 
Clinician-rated Instruments Mean (SD)       
Patient BPSS-FP Mania 
Index severity 
32.28(13.8) 13.49(8.8) 17.06(12.1) 1.66,p<.0001 1.17, <.0001 -0.34,p=.425 
BPRS Thinking Disturbance 5.15(2.6) 3.95(2.0) 3.18(0.6) 0.52, p=.038 1.21, p=.026 -0.60,p=.491 
BPRS Withdrawal-
Retardation 
3.11(1.3) 3.14(1.7) 3.10(1.6) -0.02,p=.997 0.01, p=1.0 -0.02,p=.997 
BPRS Hostile-
Suspiciousness 
6.04(2.4) 4.51(2.3) 4.00(2.0) 0.65, p=.013 0.91, p=.040 -0.23,p=.778 
BPRS Anxious-Depression 9.96(3.7) 11.40(3.3) 7.36(4.2) -0.41,p=.177 0.66, p=.102 -1.07,p=.002 
BPRS Activation 5.5(2.3) 4.35(1.8) 4.00(1.7) 0.554,p=.028 0.75, p=.082 -0.20,p=.843 
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Patient YMRS 17.30(9.5) 5.31(5.4) 4.82(3.1) 1.61,p<.0001 1.98,p<.0001 -0.12,p=.972 
Note:  
BD – Bipolar disorder diagnosis 
DD – Depressive disorder diagnosis 
NMD – No mood disorder diagnosis 
BPSS-AS-P – Bipolar Prodrome Symptom Scale–Abbreviated Screen for Patients 
BPSS-AS-P – Bipolar Prodrome Symptom Scale–Abbreviated Screen for Informant 
BPSS-FP – Bipolar Prodrome Symptom Scale–Full Prospective  
GBI-10M – General Behavior Inventory-10-item Mania scale 
YMRS – Young Mania Rating Scale 
BPRS – Brief Psychiatric Rating Scale 
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Table 3. 
 
Comparisons between the BPSS-FP Mania Index severity score and BPSS-AS-P scoring options 
 
 BPSS-AS-P 
severity 
BPSS-AS-P 
frequency 
BPSS-AS-P 
total 
BPSS-AS-P            
Threshold 
one
1
 
BPSS-AS-P            
Threshold 
two
2
 
BPSS-AS-P            
Threshold 
three
3
 
BPSS-AS-P            
Threshold 
four
4
 
Correlation with BPSS-FP 
Mania Index severity score 
.51*** .55*** .55*** .49*** .49*** .46*** .46*** 
AUC (95% CI) .71 (.59-.83) .70 (.58-.82) .73 (.61-.84) .69 (.58-.81) .68 (.56-.80) .65 (.54-.77) .64 (.52-.76) 
*** p<.0005 
1
 at least a 3 on severity (some impact) and at least a 2 on frequency (once a month) 
2
 at least a 3 on severity (some impact) and at least a 3 on frequency (once a week) 
3
at least a 4 on severity (a lot of impact) and at least a 2 on frequency (once a month) 
4
at least a 4 on severity (a lot of impact) and at least a 3 on frequency (once a week 
Note: 
BPSS-AS-P – Bipolar Prodrome Symptom Scale–Abbreviated Screen for Patients 
BPSS-FP – Bipolar Prodrome Symptom Scale–Full Prospective  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
References 
Baldessarini, R. J., Tondo, L., Vázquez, G. H., Undurraga, J., Bolzani, L., Yildiz, A., . . . Tohen, M. 
(2012). Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I 
disorder patients. World Psychiatry, 11(1), 40-46. doi:10.1016/j.wpsyc.2012.01.006 
Bellivier, F., Etain, B., Malafosse, A., Henry, C., Kahn, J. P., Elgrabli-Wajsbrot, O., . . . Leboyer, M. 
(2014). Age at onset in bipolar I affective disorder in the USA and Europe. World J Biol 
Psychiatry, 15(5), 369-376. doi:10.3109/15622975.2011.639801 
Benazzi, F., & Akiskal, H. (2003). The dual factor structure of self-rated MDQ hypomania: energized-
activity versus irritable-thought racing. Journal of Affective Disorders, 73(1-2), 59-64. 
doi:10.1016/s0165-0327(02)00333-6 
 Berk, M., Berk, L., Moss, K., Dodd, S., & Malhi, G. S. (2006). Diagnosing bipolar disorder: How can we 
do it better? Medical Joumal of Australia, 184(9), 459-462.  
Berk, M., Hallam, K., Lucas, N., Hasty, M., McNeil, C. A., Conus, P., . . . McGorry, P. D. (2007). Early 
intervention in bipolar disorders: opportunities and pitfalls. Medical Journal of Australia, 187(7 
Suppl), S11-S14.  
Berk, M., Hallam, K., Malhi, G. S., Henry, L., Hasty, M., Macneil, C., . . . McGorry, P. D. (2010). 
Evidence and implications for early intervention in bipolar disorder. Journal of Mental Health, 
19(2), 113-126. doi:10.3109/09638230903469111 
Birmaher, B., Axelson, D., Strober, M., Gill, M. K., Yang, M., Ryan, N., . . . Leonard, H. (2009). 
Comparison of manic and depressive symptoms between children and adolescents with bipolar 
spectrum disorders. Bipolar Disorders, 11(1), 52-62. doi:10.1111/j.1399-5618.2008.00659.x 
Bruchmüller, K., & Meyer, T. D. (2009). Diagnostically irrelevant information can affect the likelihood 
of a diagnosis of bipolar disorder. Journal of Affective Disorders, 116(1), 148-151. 
doi:https://doi.org/10.1016/j.jad.2008.11.018 
Colom, F., Vieta, E., Sánchez-Moreno, J., Palomino-Otiniano, R., Reinares, M., Goikolea, J. M., . . . 
Martínez-Arán, A. (2009). Group psychoeducation for stabilised bipolar disorders: 5-year 
outcome of a randomised clinical trial. The British Journal of Psychiatry, 194(3), 260-265. 
doi:10.1192/bjp.bp.107.040485 
Correll, C. U., Hauser, M., Auther, A. M., & Cornblatt, B. A. (2010). Research in people with psychosis 
risk syndrome: a review of the current evidence and future directions. Journal of Child 
Psychology and Psychiatry, 51(4), 390-431. doi:10.1111/j.1469-7610.2010.02235.x 
Correll, C. U., Hauser, M., Penzner, J. B., Auther, A. M., Kafantaris, V., Saito, E., . . . Cornblatt, B. A. 
(2014a). Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to 
their first manic episode. Bipolar Disorders, 16(5). doi:10.1111/bdi.12194 
Correll, C. U., Olvet, D. M., Auther, A. M., Hauser, M., Kishimoto, T., Carrión, R. E., . . . Cornblatt, B. 
A. (2014b). The Bipolar Prodrome Symptom Interview and Scale–Prospective (BPSS-P): 
description and validation in a psychiatric sample and healthy controls. Bipolar Disorders, 16(5), 
505-522. doi:10.1111/bdi.12209 
Davies, C. (2018). Lack of evidence to favor specific preventive interventions in psychosis: a network 
meta-analysis. World Psychiatry, 17(2), 196-209. doi:10.1002/wps.20526 
Drancourt, N., Etain, B., Lajnef, M., Henry, C., Raust, A., Cochet, B., . . . Bellivier, F. (2013). Duration 
of untreated bipolar disorder: missed opportunities on the long road to optimal treatment. Acta 
Psychiatrica Scandinavica, 127(2), 136-144. doi:10.1111/j.1600-0447.2012.01917.x 
Duax, J., Youngstrom, E., Calabrese, J., & Findling, R. (2007). Sex differences in pediatric bipolar 
disorder. Journal of Clinical Psychiatry, 68, 1565-1573. doi:10.4088/JCP.v68n1016 
Elanjithara, T. E., Frangou, S., & McGuire, P. (2011). Treatment of the early stages of bipolar disorder. 
Advances in Psychiatric Treatment, 17(4), 283-291. doi:10.1192/apt.bp.109.007047 
Faedda, G. L., Serra, G., Marangoni, C., Salvatore, P., Sani, G., Vázquez, G. H., . . . Koukopoulos, A. 
(2014). Clinical risk factors for bipolar disorders: A systematic review of prospective studies. 
Journal of Affective Disorders, 168(0), 314-321. 
doi:http://dx.doi.org/10.1016/j.jad.2014.07.013 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
BPSS-AS-P VALIDATION 22 
Findling, R. L., Nyilas, M., Forbes, R. A., McQuade, R. D., Jin, N., Iwamoto, T., . . . Chang, K. (2009). 
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a 
randomized, double-blind, placebo-controlled study. The Journal of Clinical Psychiatry, 70(10), 
1441-1451.  
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (1995). Structured clinical interview for DSM-
IV axis I disorders. New York: New York State Psychiatric Institute.  
Fusar-Poli, P., Bonoldi, I., Yung, A. R., Borgwardt, S., Kempton, M. J., Valmaggia, L., . . . McGuire, P. 
(2012). Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical 
risk. Archives of General Psychiatry, 69(3), 220-229.  
Fusar-Poli, P., Cappucciati, M., Borgwardt, S., & et al. (2016). Heterogeneity of psychosis risk within 
individuals at clinical high risk: A meta-analytical stratification. JAMA Psychiatry, 73(2), 113-
120. doi:10.1001/jamapsychiatry.2015.2324 
Fusar-Poli, P., Cappucciati, M., Rutigliano, G., Schultze‐Lutter, F., Bonoldi, I., Borgwardt, S., . . . 
Woods, S. W. (2015). At risk or not at risk? A meta‐analysis of the prognostic accuracy of 
psychometric interviews for psychosis prediction. World Psychiatry, 14(3), 322-332.  
Goldstein, B. I., Birmaher, B., Carlson, G. A., DelBello, M. P., Findling, R. L., Fristad, M., . . . 
Youngstrom, E. A. (2017). The International Society for Bipolar Disorders Task Force report on 
pediatric bipolar disorder: Knowledge to date and directions for future research. Bipolar 
Disorders, 19(7), 524-543. doi:10.1111/bdi.12556 
Hafeman, D.M., Merranko, J., Axelson, D., et al. (2016). Toward definition of a bipolar prodrome: 
dimensional predictors of bipolar spectrum disorders in at-risk youths. Am J Psychiatry, 173, 
695–704. 
Heflinger, C. A., & Hinshaw, S. P. (2010). Stigma in Child and Adolescent Mental Health Services 
Research: Understanding Professional and Institutional Stigmatization of Youth with Mental 
Health Problems and their Families. Administration and Policy in Mental Health and Mental 
Health Services Research, 37(1), 61-70. doi:10.1007/s10488-010-0294-z 
Horwitz, S. M., Demeter, C. A., Pagano, M. E., Youngstrom, E. A., Fristad, M. A., Arnold, L. E., . . . 
Findling, R. L. (2010). Longitudinal Assessment of Manic Symptoms (LAMS) study: 
background, design, and initial screening results. J Clin Psychiatry, 71(11), 1511-1517. 
doi:10.4088/JCP.09m05835yel 
Howes, O. D., Lim, S., Theologos, G., Yung, A. R., Goodwin, G. M., & McGuire, P. (2010). A 
comprehensive review and model of putative prodromal features of bipolar affective disorder. 
Psychological Medicine, 1-11. doi:10.1017/S0033291710001790 
Husky, M. M., Olfson, M., He, J.-p., Nock, M. K., Swanson, S. A., & Merikangas, K. R. (2012). Twelve-
Month Suicidal Symptoms and Use of Services Among Adolescents: Results From the National 
Comorbidity Survey. Psychiatric Services, 63(10), 989-996. doi:10.1176/appi.ps.201200058 
Jackson, A., Cavanagh, J., & Scott, J. (2003). A systematic review of manic and depressive prodromes. 
Journal of Affective Disorders, 74(3), 209-217. doi:10.1016/S0165-0327(02)00266-5 
Johnson, L., Andersson-Lundman, G., Åberg-Wistedt, A., & Mathé, A. A. (2000). Age of onset in 
affective disorder: its correlation with hereditary and psychosocial factors. Journal of Affective 
Disorders, 59(2), 139-148. doi:http://dx.doi.org/10.1016/S0165-0327(99)00146-9 
Kaiser, M. (1974). Kaiser-Meyer-Olkin measure for identity correlation matrix. Journal of the Royal 
Statistical Society, 52, 296-298.  
 Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., . . . Ryan, N. (1997). Schedule for 
Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version 
(K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child and 
Adolescent Psychiatry, 36(7), 980-988. doi:10.1097/00004583-199707000-00021 
Kline, E., Thompson, E., Demro, C., Bussell, K., Reeves, G., & Schiffman, J. (2015). Self-report 
instruments for clinical monitoring of psychosis risk states. Psychiatric Services, 67(4), 456-459.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
BPSS-AS-P VALIDATION 23 
Lam, D., & Wong, G. (1997). Prodromes, coping strategies, insight and social functioning in bipolar 
affective disorders. Psychological Medicine, 27(05), 1091-1100. 
doi:doi:10.1017/S0033291797005540 
Lam, D., & Wong, G. (2005). Prodromes, coping strategies and psychological interventions in bipolar 
disorders. Clinical Psychology Review, 25(8), 1028-1042. 
doi:https://doi.org/10.1016/j.cpr.2005.06.005 
Lam, D., Wong, G., & Sham, P. (2001). Prodromes, coping strategies and course of illness in bipolar 
affective disorder – a naturalistic study. Psychological Medicine, 31(08), 1397-1402. 
doi:doi:10.1017/S003329170100472X 
Lam, D. H., Watkins, E. R., Hayward, P., & et al. (2003). A randomized controlled study of cognitive 
therapy for relapse prevention for bipolar affective disorder: Outcome of the first year. Archives 
of General Psychiatry, 60(2), 145-152. doi:10.1001/archpsyc.60.2.145 
Leopold, K., Ritter, P., Correll, C. U. et al. (2012). Risk constellations prior to the development of bipolar 
disorders: rationale of a new risk assessment tool. J Affect Disord, 136, 1000-1010. 
Lilienfeld, S. O., & Lynn, S. J. (2014). Errors/Biases in Clinical Decision Making The Encyclopedia of 
Clinical Psychology: John Wiley & Sons, Inc. 
Lish, J. D., Dime-Meenan, S., Whybrow, P. C., Price, R. A., & Hirschfeld, R. M. (1994). The National 
Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect 
Disord, 31(4), 281-294.  
Loewy, R. L., Pearson, R., Vinogradov, S., Bearden, C. E., & Cannon, T. D. (2011). Psychosis risk 
screening with the Prodromal Questionnaire—brief version (PQ-B). Schizophrenia Research, 
129(1), 42-46.  
Marshall, M., & Rathbone, J. (2011). Early Intervention for Psychosis. Schizophrenia Bulletin, 37(6), 
1111-1114. doi:10.1093/schbul/sbr110 
Martin, D. J. (2013). Is there a clinical prodrome of bipolar disorder? A review of the evidence. Expert 
Review of Neurotherapeutics, 13(1), 89-98. doi:10.1586/ern.12.149 
Maxwell, M. (1992). Manual for the family interview for genetic studies (FIGS). Clinical neurogenetics 
branch, intramural research program. National Institute of Mental Health, Bethesda MD.  
McGorry, P., Bates, T., & Birchwood, M. (2013). Designing youth mental health services for the 21st 
century: examples from Australia, Ireland and the UK. The British Journal of Psychiatry, 
202(s54), s30-s35. doi:10.1192/bjp.bp.112.119214 
Miller, C. J., Johnson, S. L., & Eisner, L. (2009). Assessment Tools for Adult Bipolar Disorder. Clinical 
Psychology: Science and Practice, 16(2), 188-201. doi:10.1111/j.1468-2850.2009.01158.x 
Molnar, G., Feeney, M., & Fava, G. (1988). Duration and symptoms of bipolar prodromes. American 
Journal of Psychiatry, 145(12), 1576-1578.  
Pavuluri, M., Henry, D., Nadimpalli, S., O'Connor, M., & Sweeney, J. (2006). Biological risk factors in 
pediatric bipolar disorder. Biological Psychiatry, 60(9), 936-941.  
Perlis, R., Miyahara, S., Marangell, L., Wisniewski, S., Ostacher, M., DelBello, M., . . . Nierenberg, A. 
(2004). Long-term implications of early onset in bipolar disorder: Data from the first 1000 
participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). 
Biological Psychiatry, 55(9), 875-881. doi:10.1016/j.biopsych.2004.01.022 
Perry, A., Tarrier, N., Morriss, R., McCarthy, E., & Limb, K. (1999). Randomised controlled trial of 
efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and 
obtain treatment. BMJ, 318(7177), 149-153. doi:10.1136/bmj.318.7177.149 
Post, R. M., Altshuler, L. L., Kupka, R., McElroy, S. L., Frye, M. A., Rowe, M., . . . Nolen, W. A. (2017). 
More childhood onset bipolar disorder in the United States than Canada or Europe: Implications 
for treatment and prevention. Neuroscience & Biobehavioral Reviews, 74, Part A, 204-213. 
doi:http://dx.doi.org/10.1016/j.neubiorev.2017.01.022 
Post, R. M., Leverich, G. S., Kupka, R., Keck, P., McElroy, S., Altshuler, L., . . . Nolen, W. A. (2014). 
Increased parental history of bipolar disorder in the United States: association with early age of 
onset. Acta Psychiatrica Scandinavica, 129(5), 375-382. doi:10.1111/acps.12208 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
BPSS-AS-P VALIDATION 24 
Savill, M., D'ambrosio, J., Cannon, T. D., & Loewy, R. L. (2018). Psychosis risk screening in different 
populations using the Prodromal Questionnaire: a systematic review. Early Intervention in 
Psychiatry, 12(1), 3-14.  
Schwartz, S., Schultz, S., Reider, A., & Saunders, E. F. H. (2016). Daily mood monitoring of symptoms 
using smartphones in bipolar disorder: A pilot study assessing the feasibility of ecological 
momentary assessment. Journal of Affective Disorders, 191, 88-93. 
doi:https://doi.org/10.1016/j.jad.2015.11.013 
Sibisi, C. D. (1990). Sex differences in the age of onset of bipolar affective illness. The British Journal of 
Psychiatry, 156(6), 842-845. doi:10.1192/bjp.156.6.842 
Skjelstad, D. V., Malt, U. F., & Holte, A. (2010). Symptoms and signs of the initial prodrome of bipolar 
disorder: A systematic review. Journal of Affective Disorders, 126(1–2), 1-13. 
doi:http://dx.doi.org/10.1016/j.jad.2009.10.003 
Snedecor, George W. and Cochran, William G. (1989), Statistical Methods, Eighth Edition, Iowa State 
University Press. ISBN 978-0-8138-1561-9  
Topor, D. R., Swenson, L., Hunt, J. I., Birmaher, B., Strober, M., Yen, S., . . . Keller, M. (2013). Manic 
symptoms in youth with bipolar disorder: Factor analysis by age of symptom onset and current 
age. Journal of Affective Disorders, 145(3), 409-412. 
doi:https://doi.org/10.1016/j.jad.2012.06.024 
Tsuchiya, K., Byrne, M., & Mortensen, P. (2003). Risk factors in relation to an emergence of bipolar 
disorder: A systematic review. Bipolar Disorders, 5(4), 231-242. doi:10.1034/j.1399-
5618.2003.00038.x 
Van Meter, A. R., Burke, C., Youngstrom, E. A., Faedda, G. L., & Correll, C. U. (2016). The Bipolar 
Prodrome: Meta-Analysis of Symptom Prevalence Prior to Initial or Recurrent Mood Episodes. J 
Am Acad Child Adolesc Psychiatry, 55(7), 543-555. doi:10.1016/j.jaac.2016.04.017 
Venkatraman, E. S. (2000). A Permutation Test to Compare Receiver Operating Characteristic Curves. 
Biometrics, 56(4), 1134-1138. doi:10.2307/2677047 
Venkatraman, E. S., & Begg, C. B. (1996). A distribution-free procedure for comparing receiver 
operating characteristic curves from a paired experiment. Biometrika, 83(4), 835-848. 
doi:10.1093/biomet/83.4.835 
Woerner, M., Mannuzza, S., & Kane, J. (1988). Anchoring the BPRS: an aid to improved reliability. 
Psychopharmacology Bulletin, 24(1), 112-117.  
Wozniak, J., Biederman, J., Martelon, M. K., Hernandez, M., Yvonne Woodworth, K., & Faraone, S. V. 
(2013). Does sex moderate the clinical correlates of pediatric bipolar-I disorder? Results from a 
large controlled family-genetic study. Journal of Affective Disorders, 149(1‚Äì3), 269-276. 
doi:http://dx.doi.org/10.1016/j.jad.2013.01.040 
Young, R., Biggs, J., Ziegler, V., & Meyer, D. (1978). A rating scale for mania: reliability, validity and 
sensitivity. The British Journal of Psychiatry, 133(5), 429-435. doi:10.1192/bjp.133.5.429 
Youngstrom, E., Birmaher, B., & Findling, R. (2008). Pediatric bipolar disorder: Validity, 
phenomenology, and recommendations for diagnosis. Bipolar Disorders, 10, 194-214. 
doi:10.1111/j.1399-5618.2007.00563.x 
Youngstrom, E., Van Meter, A., Frazier, T., Youngstrom, J. K., & Findling, R. L. (in press). Developing 
and Validating Short Forms of the PGB-Mania and Depression Scales for Rating Youth Mood. . 
Journal of Clinical Child and Adolescent Psychology.  
Youngstrom, E., Zhao, J., Mankoski, R., Forbes, R. A., Marcus, R. M., Carson, W., . . . Findling, R. L. 
(2013). Clinical Significance of Treatment Effects with Aripiprazole versus Placebo in a Study of 
Manic or Mixed Episodes Associated with Pediatric Bipolar I Disorder. Journal of Child and 
Adolescent Psychopharmacology, 23(2), 72-79. doi:10.1089/cap.2012.0024 
Youngstrom, E. A. (2008). Developing a 10-item mania scale from the Parent General Behavior 
Inventory for children and adolescents. The Journal of Clinical Psychiatry, 69(5), 831-839.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
BPSS-AS-P VALIDATION 25 
Youngstrom, E. A., Choukas-Bradley, S., Calhoun, C. D., & Jensen-Doss, A. (2014). Clinical Guide to 
the Evidence-Based Assessment Approach to Diagnosis and Treatment. Cognitive and 
Behavioral Practice(0). doi:http://dx.doi.org/10.1016/j.cbpra.2013.12.005 
Youngstrom, E. A., Egerton, G. A., Genzlinger, J., Freeman, L. K., Rizvi, S. H., & Van Meter, A. (2018). 
Improving the global identification of bipolar spectrum disorders: Meta-analysis of the diagnostic 
accuracy of checklists. Psychol Bull, 144(3), 315-342. doi:10.1037/bul0000137 
Youngstrom, E. A., Genzlinger, J. E., Egerton, G. A., & Van Meter, A. R. (2015). Multivariate meta-
analysis of the discriminative validity of caregiver, youth, and teacher rating scales for pediatric 
bipolar disorder: Mother knows best about mania. Archives of Scientific Psychology, 3(1), 112-
137. doi:10.1037/arc0000024 
Youngstrom, E. A., Van Meter, A., Frazier, T. W., Hunsley, J., Prinstein, M. J., Ong, M.-L., & 
Youngstrom, J. K. (2017). Evidence-Based Assessment as an Integrative Model for Applying 
Psychological Science to Guide the Voyage of Treatment. Clinical Psychology: Science and 
Practice, 24(4), 331-363. doi:10.1111/cpsp.12207 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
BPSS-AS-P VALIDATION 26 
Appendix 
The BPSS-Abbreviated Screen – Patient (BPSS-AS-P) 
Pt. #.                      Date                            Office ID #____________     
 
The following screen contains statements that might or might not relate to your personal experiences. 
We are asking you about the presence and impact of these experiences, as well as about how often 
they occur. Please focus on the last year. 
 
Within the past year: 
 
 
Severity: 
How much has the experience 
had a positive or negative 
impact on your functioning? 
Frequency: 
How often has the experience 
occurred in the past year? 
 
Please read each statement carefully and circle the answer that 
BEST describes your experiences IN THE PAST YEAR.  
 
Please complete each part of this questionnaire. 
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1. I have felt unusually upbeat, super-happy, or like on top 
of the world; or got really silly or goofy. 
0 1 2 3 4 5 0 1 2 3 4 5 
2. I have felt particularly cranky, grouchy, or irritable, or 
got easily annoyed, or blew up at people. 
0 1 2 3 4 5 0 1 2 3 4 5 
3. I have felt better than others, or particularly gifted or 
talented, or made very ambitious plans 
0 1 2 3 4 5 0 1 2 3 4 5 
4. I have had times when I needed much less sleep than 
usual and was still fully rested and energetic. (i.e. I did not 
need to take a nap or go to bed early on the following day)? 
0 1 2 3 4 5 0 1 2 3 4 5 
5. I have been particularly talkative, spoke very rapidly or 
very loudly, or was difficult to interrupt. 
0 1 2 3 4 5 0 1 2 3 4 5 
6. I felt that my ideas come and go unusually easy and fast, 
that I am changing topics quickly, or that my mind is racing. 
0 1 2 3 4 5 0 1 2 3 4 5 
7. I felt unusually easily distracted by things around me, or 
needed more time than I usually do to complete tasks due to 
distractibility. 
0 1 2 3 4 5 0 1 2 3 4 5 
8. I felt unusually energetic or motivated, got things done 
more easily or faster, or got involved in more activities than 
usual. 
0 1 2 3 4 5 0 1 2 3 4 5 
9. I felt unusually restless or fidgety, could not sit still, or 
had to pace. 
0 1 2 3 4 5 0 1 2 3 4 5 
10. I either felt the urge to do things that could potentially 
be dangerous, or was involved in or actively sought out 
risky activities. 
0 1 2 3 4 5 0 1 2 3 4 5 
11. I felt that my mood changed a great deal from one 
moment or one day to the other (happy, sad or irritable), or 
that my mood goes up and down for no apparent reason. 
0 1 2 3 4 5 0 1 2 3 4 5 
 
